The $55,000-Per-Day Problem: How Agentic AI Is Cracking Study Startup Execution

Share

Execution models behind faster study startup and reduced operational delays

Study startup continues to be one of the most expensive and least optimized phases in clinical trials, where fragmented workflows, manual handoffs, and sequential execution significantly impact timelines and costs.

In this executive session, we unpack where these delays truly originate—from feasibility and regulatory preparation to site activation—and why traditional approaches struggle to keep pace.

WHAT YOU’LL ACCESS:

  • Cost anatomy of study startup delays (~$55,000/day impact)
  • Where traditional automation fails in startup workflows
  • How Agentic AI enables supervised execution across startup processes
  • Practical models to accelerate protocol-to-site activation timelines.

WHO THIS IS FOR:

  • Clinical Operations Leaders
  • Biometrics & Data Management Heads
  • CRO Delivery & Functional Leaders
  • R&D and Trial Execution Stakeholders

See how leading teams are approaching study startup differently – request access to the full presentation by filling up the form.

Fill in your details to request access.



    Upcoming events

    Meet Our Experts:

    Dr. Rachna Saralkar

    Principal Investigator, Flourish Research

    Dr. Rachna Saralkar is a double board-certified physician and Principal Investigator at Flourish Research, specializing in psychiatry, clinical informatics, and the application of AI in healthcare. She brings deep expertise at the intersection of clinical research, digital health, and emerging technologies, with a focus on advancing more efficient and patient-centered clinical development. Previously, she served as Medical Product Director at Deliberate AI, where she led the development of AI-enabled solutions for mental healthcare. She has also advised several early-stage health technology startups as a fractional Chief Medical Officer. Dr. Saralkar completed her psychiatry residency at Johns Hopkins University and holds a Master’s in Clinical Informatics Management from Stanford University School of Medicine.

    Varsha Kishore

    Product Management Leader, Maxis AI

    Varsha Kishore is a strategic Product Management Leader at Maxis AI, where she spearheads the conceptualization and end-to-end delivery of flagship Agentic AI products. With over ten years of experience in clinical IT and Pharmaceutical industry, she has evolved from a high-impact Business Analyst into a visionary leader specializing in the integration of AI frameworks within GxP-compliant clinical trials. Varsha is recognized for orchestrating high-performing cross-functional teams to drive innovation and operational excellence.

    Fill in your details to request access.



      Our Products

      Related Resources

      Harmonizing Protocols, Data, and Systems: A Practical Blueprint for Clinical Trials in 2026

      Harmonizing Protocols, Data, and Systems: A Practical Blueprint for Clinical Trials in 2026

      Real-World Evidence, Adaptive Designs & Agentic AI: Bringing It All Together

      Real-World Evidence, Adaptive Designs & Agentic AI: Bringing It All Together

      5 Operational Bottlenecks Agentic AI Can Eliminate to Speed Up Clinical Trials

      5 Operational Bottlenecks Agentic AI Can Eliminate to Speed Up Clinical Trials